Showing 4581-4590 of 5646 results for "".
- Researchers Use Patients’ Cells to Test Gene Therapy for a Form of Leber Congenital Amauroshttps://modernod.com/news/researchers-use-patients-cells-to-test-gene-therapy-for-a-form-of-leber-congenital-amauros/2478810/Scientists at the National Eye Institute (NEI) have developed a promising gene therapy strategy for a rare disease that causes severe vision loss in childhood. A form of Leber congenital amaurosis, the disease is caused by autosomal-dominant mutations in the CRX gene, which are ch
- Influence of Patient Mask Wearing on Ocular Injection-Related Infection Unclearhttps://modernod.com/news/influence-of-patient-mask-wearing-on-ocular-injection-related-infection-unclear/2478807/Pre-pandemic research suggests that mask wearing by clinicians may reduce infectious endophthalmitis in patients receiving ocular injections, and that a no-talking policy can also help. But the influence of mask wearing by patients themselves still remains to be precisely defined, ressearchers sa
- Lilly Teams Up With GSK, Vir to Test Antibody Combination Against COVID-19https://modernod.com/news/lilly-teams-up-with-gsk-vir-to-test-antibody-combination-against-covid-19/2478808/Eli Lilly is expanding the ongoing phase 2 BLAZE-4 trial to include testing a combination of its antibody treatment bamlanivimab with VIR-7831, a dual-action antibody being co-developed by GlaxoSmithKline and Vir Biotechnology, for use in low-risk patients with mild-to-moderate COVID-19, the comp
- Optomed Establishes a Scientific Advisory Boardhttps://modernod.com/news/optomed-establishes-a-scientific-advisory-board/2478806/Optomed announced it is establishing an international scientific advisory board consisting of globally recognized and scientifically merited medical doctors specializing in ophthalmology and neuro-ophthalmology, with advanced experience on artificial intelligence applied to detection of ophthalmi
- Verana Health Announces Real-World Data and Data Science Collaboration Agreement with Janssenhttps://modernod.com/news/verana-health-announces-real-world-data-and-data-science-collaboration-agreement-with-janssen/2478805/Verana Health announced a research collaboration agreement with Janssen Research & Development (Janssen). The research collaboration will focus on curating real-world data and driving data science applications in the areas of ophthalmology and urology. Financial terms of the agreement
- Neurophth Therapeutics Appoints Qiutang Li, PhD, as Chief Scientific Officerhttps://modernod.com/news/neurophth-therapeutics-appoints-qiutang-li-phd-as-chief-scientific-officer/2478800/Wuhan Neurophth Biotechnology, a developer of AAV-delivered gene therapies for the treatment of ocular diseases, announced the appointment of Qiutang Li, PhD, as Chief Scientific Officer. She will be mainly responsible for the company’s global R&D, IND portfolio strategy, and the establ
- DORC Announces Health Canada Approval of Tissueblue for Staining of the ILM During Vitreoretinal Surgeryhttps://modernod.com/news/dorc-announces-health-canada-approval-of-tissueblue-for-staining-of-the-ilm-during-vitreoretinal-surgery/2478799/DORC has announced that it has received notification from Health Canada that the application for Tissueblue (Brilliant Blue G Ophthalmic Solution 0.025%) has been approved and will be available later in 2021 via Innovamed, DORC’s local distributor partner. Tissueblue is the first dye approved by
- Zenni Releases New Anti-Fog Glasses Lenses to Address Mask-Related Fogginghttps://modernod.com/news/zenni-releases-new-anti-fog-glasses-lenses-to-address-mask-related-fogging/2478797/Zenni announced a 2-in-1 anti-fog + anti-reflective lens solution to solve a pain point for glasses wearers during the pandemic. Developed in 2020 as a response to the pervasive consumer issue of glasses fogging up while wearing face coverings, these new anti-fog coated lenses are the only low pr
- Merck Shuts Down Covid Vaccine Program After Lackluster Datahttps://modernod.com/news/merck-shuts-down-covid-vaccine-program-after-lackluster-data/2478791/Merck is discontinuing development of its two experimental Covid-19 vaccines after early trial data showed they failed to generate immune responses comparable to a natural infection or existing vaccines, according to a Bloomberg
- Genentech’s Faricimab Meets Primary Endpoint in Two Global Phase 3 Studies in Wet AMDhttps://modernod.com/news/genentechs-faricimab-meets-primary-endpoint-in-two-global-phase-3-studies-in-wet-amd/2478792/Genentech announced positive topline results from two identically designed global phase 3 studies, TENAYA and LUCERNE, evaluating its investigational bispecific antibody, faricimab, in people living with wet age-related macular degeneration (AMD). Both studies met their primary endpoint and showe